Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Pape'ete Political Trends.
Press releases published on August 4, 2025

ALTO NEUROSCIENCE, INC. (NYSE: ANRO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Alto Neuroscience, Inc. Investors of Upcoming Deadline
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Alto Neuroscience, Inc. (“Alto” or the “Company”) (NYSE: ANRO) investors of an upcoming deadline involving a securities fraud class …

LOCKHEED MARTIN CORPORATION (NYSE: LMT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Lockheed Martin Corporation Investors of Upcoming Deadline
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lockheed Martin Corporation (“Lockheed Martin” or the “Company”) (NYSE: LMT) investors of an upcoming deadline involving a …

FLYWIRE CORPORATION (NASDAQ: FLYW) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Flywire Corporation Investors of Upcoming Deadline
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW) investors of an upcoming deadline involving a securities fraud …

MaxCyte Signs Platform License Agreement with Adicet Bio
MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of Adicet’s gamma delta T cell therapy gene edited programs ROCKVILLE, Md., Aug. 04, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering …

Cerence AI Files Complaint with the International Trade Commission against Sony and TCL
BURLINGTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that it has filed a complaint with the United States International Trade …

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
TORONTO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today …